Back to Search
Start Over
A revised international prognostic score system for Waldenström’s macroglobulinemia
- Source :
- Leukemia. 33:2654-2661
- Publication Year :
- 2019
- Publisher :
- Springer Science and Business Media LLC, 2019.
-
Abstract
- A staging system was developed a decade ago for patients with Waldenstrom’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised staging system could better capture prognosis of WM patients in the chemoimmunotherapy era. We developed a revised system based on data from 492 symptomatic patients with at least 3 years and a median of 7 years of follow up while an independent validation cohort included 229 symptomatic patients. We identified age (≤65 vs 66–75 vs ≥76 years), b2-microglobulin ≥ 4 mg/L, serum albumin 65 years and
- Subjects :
- 0301 basic medicine
Cancer Research
medicine.medical_specialty
Proportional hazards model
business.industry
Clinical study design
Macroglobulinemia
Hematology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
Chemoimmunotherapy
030220 oncology & carcinogenesis
Internal medicine
Severity of illness
medicine
Rituximab
business
Prospective cohort study
Survival rate
medicine.drug
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi...........14c19eeee1139129d756f0cb3eac53f5